Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Didier Blaise

Showing results (81-90 of 510) with videos related to

Pageof 51
Sort By:
Blood|December 18, 2016
Can a reduced-intensity conditioning regimen cure blastic plasmacytoid dendritic cell neoplasm?Mathieu Leclerc, Régis Peffault de Latour, Mauricette Michallet, et al.
Nature Clinical Practice. Oncology|April 10, 2008
Transplantation of allogeneic hematopoietic stem cells: an emerging treatment modality for solid tumorsTaner Demirer, Lisbeth Barkholt, Didier Blaise, et al.
Leukemia & Lymphoma|February 11, 2014
Efficacy and safety of lenalinomide combined with rituximab in patients with relapsed/refractory diffuse large B-cell lymphomaVadim Ivanov, Diane Coso, Bruno Chetaille, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|July 30, 2020
Reduced-Intensity versus Myeloablative Conditioning in Cord Blood Transplantation for Acute Myeloid Leukemia (40-60 years) across Highly Mismatched HLA Barriers-On Behalf of Eurocord and the Cellular Therapy & Immunobiology Working Party (CTIWP) of EBMTVipul Sheth, Fernanda Volt, Jaime Sanz, et al.
The Lancet. Haematology|September 23, 2024
Sexual health and emotional wellbeing of patients with haematological malignancies: general reviewTamim Alsuliman, Reyes María Martín Rojas, Nour Moukalled, et al.
Transfusion|October 19, 2019
A matched-pair analysis reveals marginally reduced CD34+ cell mobilization on second occasion in 27 related donors who underwent peripheral blood stem cell collection twice at the same institutionMelanie Velier, Angela Granata, Stefania Bramanti, et al.
British Journal of Haematology|February 23, 2018
Anti-thymocyte globulin for graft-versus-host disease prophylaxis in patients with intermediate- or high-risk acute myeloid leukaemia undergoing reduced-intensity conditioning allogeneic stem cell transplantation in first complete remission - a survey on behalf of the Acute Leukaemia Working Party of the European Society for Blood and Marrow TransplantationYishai Ofran, Eric Beohou, Myriam Labopin, et al.
Cytotherapy|March 8, 2021
Non-cryopreserved hematopoietic stem cells in autograft patients with lymphoma: a matched-pair analysis comparing a single center experience with the use of cryopreserved stem cells reported to the European Society for Blood and Marrow Transplantation registryMohamed-Amine Bekadja, Ariane Boumendil, Didier Blaise, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|May 14, 2017
Haploidentical Allogeneic Hematopoietic Cell Transplantation for Multiple Myeloma Using Post-Transplantation Cyclophosphamide Graft-versus-Host Disease ProphylaxisLuca Castagna, Alberto Mussetti, Raynier Devillier, et al.
Experimental Hematology|October 24, 2012
Rituximab, fludarabine, and total body irradiation as conditioning regimen before allogeneic hematopoietic stem cell transplantation for advanced chronic lymphocytic leukemia: long-term prospective multicenter studyMauricette Michallet, Gerard Socié, Mohamad Mohty, et al.
Pageof 51

Showing results (81-90 of 510) with videos related to

Sort By:
Pageof 51
Blood|December 18, 2016
Can a reduced-intensity conditioning regimen cure blastic plasmacytoid dendritic cell neoplasm?Mathieu Leclerc, Régis Peffault de Latour, Mauricette Michallet, et al.
Nature Clinical Practice. Oncology|April 10, 2008
Transplantation of allogeneic hematopoietic stem cells: an emerging treatment modality for solid tumorsTaner Demirer, Lisbeth Barkholt, Didier Blaise, et al.
Leukemia & Lymphoma|February 11, 2014
Efficacy and safety of lenalinomide combined with rituximab in patients with relapsed/refractory diffuse large B-cell lymphomaVadim Ivanov, Diane Coso, Bruno Chetaille, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|July 30, 2020
Reduced-Intensity versus Myeloablative Conditioning in Cord Blood Transplantation for Acute Myeloid Leukemia (40-60 years) across Highly Mismatched HLA Barriers-On Behalf of Eurocord and the Cellular Therapy & Immunobiology Working Party (CTIWP) of EBMTVipul Sheth, Fernanda Volt, Jaime Sanz, et al.
The Lancet. Haematology|September 23, 2024
Sexual health and emotional wellbeing of patients with haematological malignancies: general reviewTamim Alsuliman, Reyes María Martín Rojas, Nour Moukalled, et al.
Transfusion|October 19, 2019
A matched-pair analysis reveals marginally reduced CD34+ cell mobilization on second occasion in 27 related donors who underwent peripheral blood stem cell collection twice at the same institutionMelanie Velier, Angela Granata, Stefania Bramanti, et al.
British Journal of Haematology|February 23, 2018
Anti-thymocyte globulin for graft-versus-host disease prophylaxis in patients with intermediate- or high-risk acute myeloid leukaemia undergoing reduced-intensity conditioning allogeneic stem cell transplantation in first complete remission - a survey on behalf of the Acute Leukaemia Working Party of the European Society for Blood and Marrow TransplantationYishai Ofran, Eric Beohou, Myriam Labopin, et al.
Cytotherapy|March 8, 2021
Non-cryopreserved hematopoietic stem cells in autograft patients with lymphoma: a matched-pair analysis comparing a single center experience with the use of cryopreserved stem cells reported to the European Society for Blood and Marrow Transplantation registryMohamed-Amine Bekadja, Ariane Boumendil, Didier Blaise, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|May 14, 2017
Haploidentical Allogeneic Hematopoietic Cell Transplantation for Multiple Myeloma Using Post-Transplantation Cyclophosphamide Graft-versus-Host Disease ProphylaxisLuca Castagna, Alberto Mussetti, Raynier Devillier, et al.
Experimental Hematology|October 24, 2012
Rituximab, fludarabine, and total body irradiation as conditioning regimen before allogeneic hematopoietic stem cell transplantation for advanced chronic lymphocytic leukemia: long-term prospective multicenter studyMauricette Michallet, Gerard Socié, Mohamad Mohty, et al.
Pageof 51